New craniofacial bone engineering through miR-23-27-24 cluster mediated osteogenic-angiogenic coupling
通过miR-23-27-24簇介导的成骨-血管生成耦合的新颅面骨工程
基本信息
- 批准号:10252923
- 负责人:
- 金额:$ 32.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-03 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAlkaline PhosphataseAlveolarAmericanAngiogenesis InhibitorsAnimal ModelAnimalsBCL2L11 geneBinding SitesBiomedical EngineeringBlood VesselsBone MarrowBone RegenerationBone ResorptionBone remodelingCalvariaCell Culture TechniquesCell ProliferationCoupledCouplingCraniofacial AbnormalitiesDataDefectDepositionEndothelial CellsEngineeringEquilibriumFamilyGene ExpressionGenesGrowthHealthHealth BenefitHeightHomeostasisImplantIn VitroInflammationInflammatoryLaboratoriesMediatingMethodologyMicroRNAsMineralsMolecularNatural regenerationNotch Signaling PathwayOralOsteogenesisPeriodontal DiseasesPeriodontitisPhysiologyReagentRoleSmall RNATestingTissue EngineeringTissuesTubeUntranslated RegionsVascularizationangiogenesisbaseblood vessel developmentbonebone cellbone engineeringbone losscontrolled releasecraniofacial boneexperimental studyimplantationimprovedin vitro Modelin vivomembermonocytenanoparticlenovelnovel therapeuticsosteoclastogenesisosteogenicoverexpressionprogenitorrestorationscaffoldsubcutaneoustherapeutic miRNAtool
项目摘要
Blood vessels affect all aspects of bone physiology, including mineral growth
during new bone formation. To engineer bone as a vascularized tissue we have now
focused on microRNAs as molecular engineering tools because of their ability to
reversibly target multiple regulatory networks. Recent studies from our and other
laboratories have demonstrated that miRNAs promote bone lineage differentiation and
new bone formation through WNT, BMP, and Notch signaling pathways and also control
bone resorption. In our quest for novel therapeutics that promote coupled bone
remodeling and angiogenesis for the treatment of large bone defects we have here
identified the miR-27~23~24 microRNA cluster as a highly promising miRNA candidate
reagent. Our preliminary analysis revealed multiple miR-23 and miR-27 binding sites on
the untranslated region (UTR) of the Wnt antagonist Sfrp1 and Nlk 3’, which in
conjunction with miR-24 binding sites on the UTR of the angiogenesis inhibitors BIM
and SEMA4A demonstrate the potential of the miR-27-23-24 microRNA cluster for
coupled osteogenic and angiogenic molecular engineering strategies.
In preliminary studies, we have demonstrated that miR-23-27-24 cluster member
expression was greatly reduced in inflammatory tissues. Conversely, miR-27 mimic
treatment of diseased periodontal tissues with severe vertical bone defects resulted in
unexpectedly extensive new bone formation as evidenced by 80% complete restoration
of vertical bone height and new deposition of mineralized tissue in large calvarial bone
defects after 8 weeks of miR-27 application. Implants containing PEG-PLGA-PLL-miR-
27 nanoparticles promoted matrix remodeling, new blood vessel formation, and
substantial amounts of calvarial bone regeneration in critical size defects. On a cellular
level, miR-27 overexpression increased alkaline phosphatase activity and bone marker
gene expression, while inhibition of miR-27 resulted in a dramatic increase in the
expression of osteoclastogenesis related genes and bone resorption. Both miR-24 and
miR-27 promoted endothelial cell proliferation and blood vessel tube formation.
Together, these exciting preliminary data prompted us to propose a novel molecular
engineering strategy that will harness the osteogenic and pro-angiogenic qualities of
miR-23/27/24 cluster members in conjunction with suitable scaffolds and re-balance
alveolar and calvarial bone homeostasis for new craniofacial bone formation.
血管影响骨骼生理学的各个方面,包括矿物质生长
在新骨形成过程中。为了将骨骼设计为血管化组织,我们现在拥有
专注于将 microRNA 作为分子工程工具,因为它们能够
可逆地针对多个监管网络。我们和其他人的最新研究
实验室已经证明 miRNA 促进骨谱系分化
通过 WNT、BMP 和 Notch 信号通路控制新骨形成
骨吸收。在我们寻求促进骨耦合的新疗法的过程中
我们这里有用于治疗大骨缺损的重塑和血管生成
鉴定出 miR-27~23~24 microRNA 簇是非常有前途的 miRNA 候选者
试剂。我们的初步分析揭示了多个 miR-23 和 miR-27 结合位点
Wnt 拮抗剂 Sfrp1 和 Nlk 3' 的非翻译区 (UTR),其中
与血管生成抑制剂 BIM 的 UTR 上的 miR-24 结合位点结合
和 SEMA4A 证明了 miR-27-23-24 microRNA 簇的潜力
耦合成骨和血管生成分子工程策略。
在初步研究中,我们已经证明 miR-23-27-24 簇成员
炎症组织中的表达大大降低。相反,miR-27 模拟
治疗具有严重垂直骨缺损的患病牙周组织导致
80% 的完全修复证明出乎意料地广泛的新骨形成
大颅骨中垂直骨高度的变化和矿化组织的新沉积
应用 miR-27 8 周后出现缺陷。含有 PEG-PLGA-PLL-miR- 的植入物
27 纳米颗粒促进基质重塑、新血管形成,
临界尺寸缺损处有大量颅骨再生。在蜂窝网络上
水平,miR-27 过表达增加碱性磷酸酶活性和骨标志物
基因表达,而抑制 miR-27 导致
破骨细胞生成相关基因和骨吸收的表达。 miR-24 和
miR-27促进内皮细胞增殖和血管形成。
总之,这些令人兴奋的初步数据促使我们提出了一种新的分子
工程策略将利用成骨和促血管生成的特性
miR-23/27/24簇成员与合适的支架结合并重新平衡
牙槽骨和颅骨骨稳态,促进新颅面骨的形成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xianghong Luan其他文献
Xianghong Luan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xianghong Luan', 18)}}的其他基金
New craniofacial bone engineering through miR-23-27-24 cluster mediated osteogenic angiogenic coupling
通过 miR-23-27-24 簇介导的成骨血管生成耦合的新颅面骨工程
- 批准号:
10935538 - 财政年份:2023
- 资助金额:
$ 32.49万 - 项目类别:
New craniofacial bone engineering through miR-23-27-24 cluster mediated osteogenic-angiogenic coupling
通过miR-23-27-24簇介导的成骨-血管生成耦合的新颅面骨工程
- 批准号:
10403608 - 财政年份:2020
- 资助金额:
$ 32.49万 - 项目类别:
New craniofacial bone engineering through miR-23-27-24 cluster mediated osteogenic-angiogenic coupling
通过miR-23-27-24簇介导的成骨-血管生成耦合的新颅面骨工程
- 批准号:
10619453 - 财政年份:2020
- 资助金额:
$ 32.49万 - 项目类别:
Small molecule microenvironment design for craniofacial bone regeneration
颅面骨再生的小分子微环境设计
- 批准号:
10190888 - 财政年份:2009
- 资助金额:
$ 32.49万 - 项目类别:
Epigenetics of Dental Stem Cells: Markers and CP27 Function
牙干细胞的表观遗传学:标记物和 CP27 功能
- 批准号:
7567145 - 财政年份:2009
- 资助金额:
$ 32.49万 - 项目类别:
Ameloblastin Function in Periodontal Development
成釉细胞在牙周发育中的功能
- 批准号:
7840797 - 财政年份:2009
- 资助金额:
$ 32.49万 - 项目类别:
Small molecule microenvironment design for craniofacial bone regeneration
颅面骨再生的小分子微环境设计
- 批准号:
10000905 - 财政年份:2009
- 资助金额:
$ 32.49万 - 项目类别:
Epigenetics of Dental Stem Cells: Markers and CP27 Function
牙干细胞的表观遗传学:标记物和 CP27 功能
- 批准号:
7896681 - 财政年份:2009
- 资助金额:
$ 32.49万 - 项目类别:
Enamel Structure Sophistication throuth Amelogenin Evolution
牙釉质结构通过牙釉蛋白进化而变得复杂
- 批准号:
8111783 - 财政年份:2008
- 资助金额:
$ 32.49万 - 项目类别:
Ameloblastin Function in Periodontal Development
成釉细胞在牙周发育中的功能
- 批准号:
8089487 - 财政年份:2008
- 资助金额:
$ 32.49万 - 项目类别:
相似海外基金
The role of tissue nonspecific alkaline phosphatase in brain endothelial cell homeostasis
组织非特异性碱性磷酸酶在脑内皮细胞稳态中的作用
- 批准号:
10220574 - 财政年份:2021
- 资助金额:
$ 32.49万 - 项目类别:
Post-Transcriptional Processing of the Small Intestinal Alkaline Phosphatase in the Postnatal Developing Pig
产后发育猪小肠碱性磷酸酶的转录后加工
- 批准号:
RGPIN-2016-05827 - 财政年份:2021
- 资助金额:
$ 32.49万 - 项目类别:
Discovery Grants Program - Individual
The role of tissue nonspecific alkaline phosphatase in brain endothelial cell homeostasis
组织非特异性碱性磷酸酶在脑内皮细胞稳态中的作用
- 批准号:
10413987 - 财政年份:2021
- 资助金额:
$ 32.49万 - 项目类别:
The role of tissue nonspecific alkaline phosphatase in brain endothelial cell homeostasis
组织非特异性碱性磷酸酶在脑内皮细胞稳态中的作用
- 批准号:
10601067 - 财政年份:2021
- 资助金额:
$ 32.49万 - 项目类别:
Selective targeting of human alkaline phosphatase isozymes
选择性靶向人碱性磷酸酶同工酶
- 批准号:
10359823 - 财政年份:2020
- 资助金额:
$ 32.49万 - 项目类别:
Dietary induction of intestinal alkaline phosphatase intended to detoxify endotoxin and analysis of its mechanism of action.
膳食诱导肠道碱性磷酸酶解毒内毒素及其作用机制分析。
- 批准号:
20K05936 - 财政年份:2020
- 资助金额:
$ 32.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional analysis of alkaline phosphatase, a stem cell marker, using human deciduous dental pulp cells derived from the patient with Hypophosphatasia (HPP)
使用源自低磷酸酯酶症 (HPP) 患者的人乳牙牙髓细胞对干细胞标记物碱性磷酸酶进行功能分析
- 批准号:
20K10210 - 财政年份:2020
- 资助金额:
$ 32.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding the role of tissue non-specific alkaline phosphatase in osteogenesis for the therapy of hypophosphatasia.
了解组织非特异性碱性磷酸酶在成骨作用中的作用,以治疗低磷酸酯酶症。
- 批准号:
20K16894 - 财政年份:2020
- 资助金额:
$ 32.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Selective targeting of human alkaline phosphatase isozymes
选择性靶向人碱性磷酸酶同工酶
- 批准号:
10117265 - 财政年份:2020
- 资助金额:
$ 32.49万 - 项目类别:
Post-Transcriptional Processing of the Small Intestinal Alkaline Phosphatase in the Postnatal Developing Pig
产后发育猪小肠碱性磷酸酶的转录后加工
- 批准号:
RGPIN-2016-05827 - 财政年份:2020
- 资助金额:
$ 32.49万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




